Literature DB >> 2456340

Analysis of the molecular basis of HLA-A3 recognition by cytotoxic T cells using defined mutants of the HLA-A3 molecule.

M L Jelachich1, E P Cowan, R V Turner, J E Coligan, W E Biddison.   

Abstract

The structure-function relationships in human class I HLA molecules have been examined by the analysis of two T cell-defined subtypes of HLA-A3 (A3.1 and A3.2). These subtypes differ by two amino acid residues that are located at positions 152 (GluA3.1 vs ValA3.2) and 156 (LeuA3.1 vs GlnA3.2). By the methods of site-directed mutagenesis and DNA-mediated gene transfer, mammalian cell transfectants have been produced that express only one of the above A3.2 amino acid residues at either position 152 or position 156. Previous studies using murine transfectants have shown that A3.1- and A3.2-expressing cells can be distinguished by A3.1-restricted type A influenza virus-specific CTL and A3.2-allospecific CTL and have implied that amino acid position 152 plays a key role in this specificity. To test whether these results were a function of the virus specificity, the alloantigen, or the cell type expressing the class I molecules, we have tested the recognition of human and murine cell transfectants by A3.1-restricted, A/JAP/305/57 and B/Ann Arbor-specific CTL and by A3.1- and A3.2-allospecific CTL. The results indicate that the Glu at position 152 is critical for recognition by all of the A3.1-restricted CTL populations tested and 15 of 16 of the A3.1-allospecific CTL populations tested. The A3.1 Leu at position 156 was sufficient for recognition by only one A3.1-allospecific CTL line. Substitution of the charged Glu residue for the polar Gln at position 156 of A3.2 affected recognition of some but not all A3.2-alloreactive CTL. These data demonstrate that the structural basis for epitopes that are recognized by almost all CTL that discriminate between A3.1 and A3.2 is primarily the amino acid at position 152. The implications of these data for Ag presentation and CTL recognition are discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2456340

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  A cluster of mutations in HLA-A2 alpha 2 helix abolishes peptide recognition by T cells.

Authors:  R J Moots; M Matsui; L Pazmany; A J McMichael; J A Frelinger
Journal:  Immunogenetics       Date:  1991       Impact factor: 2.846

2.  Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides.

Authors:  M DiBrino; K C Parker; J Shiloach; M Knierman; J Lukszo; R V Turner; W E Biddison; J E Coligan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

3.  Structural studies of an HLA-A03 alloantigenic epitope defined by a human hybridoma antibody.

Authors:  W E Biddison; R W Anderson; E P Cowan; R V Turner; J E Coligan; K Hannestad; T Hansen; W L Maloy
Journal:  Immunogenetics       Date:  1989       Impact factor: 2.846

4.  Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte clone that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein.

Authors:  K Takahashi; L C Dai; T R Fuerst; W E Biddison; P L Earl; B Moss; F A Ennis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-11-15       Impact factor: 11.205

5.  Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV.

Authors:  M J Koziel; D Dudley; N Afdhal; Q L Choo; M Houghton; R Ralston; B D Walker
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

6.  The structure of the antigen-binding groove of major histocompatibility complex class I molecules determines specific selection of self-peptides.

Authors:  G M van Bleek; S G Nathenson
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

7.  Alloreactive cytotoxic T lymphocytes recognize epitopes determined by both the alpha helices and beta sheets of the class I peptide binding site.

Authors:  H D Hunt; T I Munitz; L R Pease
Journal:  J Exp Med       Date:  1992-03-01       Impact factor: 14.307

8.  Polymorphic DQ alpha and DQ beta interactions dictate HLA class II determinants of allo-recognition.

Authors:  W W Kwok; E Mickelson; S Masewicz; E C Milner; J Hansen; G T Nepom
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

9.  I-A alpha polymorphic residues that determine alloreactive T cell recognition.

Authors:  M Pierres; S Marchetto; P Naquet; D Landais; J Peccoud; C Benoist; D Mathis
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

10.  Donor major histocompatibility complex (MHC) peptides are presented by recipient MHC molecules during graft rejection.

Authors:  G Benichou; P A Takizawa; C A Olson; M McMillan; E E Sercarz
Journal:  J Exp Med       Date:  1992-01-01       Impact factor: 14.307

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.